Pfizer Settles Protonix Off-Label Allegations – Pricing Investigation Still Unresolved

Pfizer finalizes a $55 million settlement with the Department of Justice concerning Wyeth’s Protonix promotional practices; a separate probe of alleged bundling of Protonix sales to hospitals continues.